FDA has issued a solicitation for a mobile app that will facilitate rapid communication of adverse events during public health emergencies. The app will supplement FDA’s MedWatch reporting program.
FDA has issued a solicitation for a mobile app that will facilitate rapid communication of adverse events during public health emergencies. The app will supplement FDA’s MedWatch reporting program.